The largest database of trusted experimental protocols

61 protocols using fragment analyzer system

1

Exosomal Small RNA Sequencing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small RNA sequencing was performed by Lexogen GmbH without bioinformatics or subsequent analysis. RNA integrity was assessed on a Fragment Analyzer System using the DNF-471 RNA Kit (Agilent). Multiplexed sequencing-ready indexed small RNA libraries were prepared using the Small RNA-Seq Library Prep Kit for Illumina (052UG128V0110) following the procedure as described in the User’s Guide. For library preparation, an average of 1 ng of the total RNA sample was used as an input without small RNA enrichment. The quality control of the library preparation was checked by HS DNA assay for the Fragment Analyzer System (Agilent). The concentration of the resulting libraries was quantified using a Qubit dsDNA HS assay (Thermo Fisher). Next-Generation Sequencing (NGS) was performed on the Illumina NextSeq 2000 platform.
Bioinformatics analysis was performed using the exceRpt pipeline (version 4.3.2) (67 (link)). Read Per Million (RPM) normalized readcounts were used for the analysis of differential expression in exosomal small RNA, employing the glmQL method within the edgeR package (version 3.38.4) (68 (link)). The raw and processed sequencing data are available in the GSE241815 dataset at Gene Expression Omnibus (GEO).
+ Open protocol
+ Expand
2

FFPE RNA Sequencing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepa 1-6 FFPE scrolls were processed for DNA and RNA extraction using a Quick-DNA/RNA FFPE Miniprep Kit with on-column DNase digestion for the RNA preps (Cat. # R1009; Zymo Research). RNA was assessed for mass concentration using the Qubit RNA Broad Range Assay Kit (Cat. # Q10211; Invitrogen) with a Qubit 4 fluorometer (Cat. # Q33238; Invitrogen). RNA quality was assessed with a Standard Sensitivity RNA Analysis Kit (Cat. # DNF-471-0500; Agilent) on a Fragment Analyzer System (Cat. # M5310AA; Agilent). Sequencing libraries were prepared using TruSeq Stranded Total RNA Library Prep Gold (Cat. # 20020599; Illumina). RNA DV200 scores were used to determine fragmentation times. Libraries were assessed for mass concentration using a Qubit 1X dsDNA HS Assay Kit (Cat. # Q33231; Invitrogen) with a Qubit 4 fluorometer (Cat. # Q33238; Invitrogen). Library fragment size was assessed with a High Sensitivity NGS Fragment Analysis Kit (Cat. # DNF-474-0500; Agilent) on a Fragment Analyzer System (Cat. # M5310AA; Agilent). Libraries were functionally validated with a KAPA Universal Library Quantification Kit (Cat. # 07960140001; Roche). Sequencing was performed to generate paired-end reads (2 × 100 bp) with a 200-cycle S1 flow cell on a NovaSeq 6000 sequencing system (Illumina).
+ Open protocol
+ Expand
3

RNA-Seq Library Preparation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA for sequencing was purified by phenol-chloroform extraction from grinded livers. In the case of Hepa1c1c7 cells, RNA for sequencing was purified with the use of the SurePrep Nuclear RNA Purification Kit from Fisher Scientific. RNA was quantified using the Fragment Analyzer System (Advanced Analytical Technologies), and 1 ng total RNA was used to prepare indexed RNA-seq libraries using the SMARTer Stranded Total RNA-Seq - Pico Input Mammalian Kit (Takara), omitting the depletion of ribosomal cDNA with the ZapR step. Illumina libraries were quantified using the Fragment Analyzer and by qPCR and sequenced on an Illumina MiSeq using 75-nt paired-end reads. Reads were aligned to the mouse 45S rRNA precursor (GenBank: NR_046233.2) using BWA-MEM v.0.7.12. Sequence depth at each position was then calculated using SAMtools depth v.1.3. The depth at each position was then normalized for sequence volume by scaling each value to correspond to the depth per 10,000,000 total depth for each sample. The normalized depths for each sample group were then averaged and a ratio of Eif3m/Control was calculated for each position. Ratios were then converted to bedGraph format and visualized with IGV v.2.3.
+ Open protocol
+ Expand
4

High-throughput Viral Amplicon Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mHVRs for TEDa2cl4 were amplified according to the protocol and primers proposed in [33 (link)]. Amplicons were then purified using the magnetic beads Agencourt AMPure XP-PCR Purification (Beckman Genomics, USA). The concentration of the purified amplicons was controlled using Qubit Fluorometer 2.0 (Invitrogen, USA). The library was validated using the Fragment Analyzer system (Advanced Analytical Technologies, USA). The library was sequenced on an Illumina MiSeq using a 500 cycle v2 kit (Illumina, San Diego, USA). The mHVR reads from TEV55cl1 and PalDa20cl3 were previously published in [33 (link)].
+ Open protocol
+ Expand
5

Chromatin Immunoprecipitation Sequencing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two biological replicates were performed for each ChIP-seq experiment. ChIP-seq experiments were performed as in ref. 20 (link). Briefly, nuclei were extracted in lysis buffer (140 mM NaCl, 15 mM HEPES [pH 7.6], 1 mM EDTA, 0.5 mM EGTA, 1% TritonX100, 0.5 mM DTT, 0.1% Sodium Deoxycholate, 10 mM Sodium Butyrate, 1× Protease Inhibitors) and subsequently subjected to ultrasound treatment (Covaris E220, 45 s, peak power 75, duty factor 10, cycles burst 200). Fixed chromatin was then sheared using Covaris E220 (900 s, peak power 140, duty factor 5, cycle burst 200) and precleared overnight. Each sample was incubated with the relevant antibody and concentration (See Supplementary Table 1) for at least 4 h at 4 °C. Samples were then washed, eluted and decrosslinked overnight by incubation at 65 °C. Next, samples were treated with RNaseA (50 μg/mL final concentration) for 30 min at 37 °C and ProteinaseK (200 μg/mL, final) for 3 h at 56 °C. DNA was purified and libraries were prepared according to manufacturer’s instructions using the NEBNext Ultra II DNA Library Prep Kit for Illumina. Libraries were quality controlled by capillary electrophoresis on the Fragment Analyzer system (Advanced Analytical). Sequencing was done using the HiSeq, NextSeq or NovaSeq Illumina platform together with the paired end sequencing option.
+ Open protocol
+ Expand
6

Investigating PCCA Pseudoexon Splicing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lysis was performed by adding TRIzol Reagent (Ambion, Carlsbad, CA). After homogenization of the cell lysates, total RNA was extracted by phase separation with chloroform and precipitation in isopropanol. cDNA was synthesized from 0.5 μg RNA using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) in 10-μL reactions. To investigate splicing patterns of the minigene PCCA pseudoexon, the region from PCCA exon 14 to the bovine growth hormone (BGH) termination sequence of the pcDNA3.1(+) backbone was amplified (PCCA.ex14.F: 5′-ACCCCTACAAGTCTTTTGGTTTAC-3′ and BGH.R: 5′- AACTAGAAGGCACAGTCGAGGCTG-3′) from 1 μL cDNA using TEMPase Hot Start 2× Master Mix (Ampliqon, Odense M, Denmark) in 10-μL PCR reactions. To investigate the splicing patterns of the endogenous PCCA pseudoexon, the region from PCCA exon 14 to exon 15 was amplified (PCCA.ex14.F and PCCA.ex15.R: 5′-TTCCTGGTTGGATGCCACTG-3′). (PCR program: 95°C for 15 min, 30 cycles at 95°C for 30 s, 60°C (minigene)/51°C (endogenous) for 30 s, and 72°C for 20 s, followed by 72°C for 5 min.) PCR samples were visualized on 1.5% SeaKem LE agarose (Lonza, Rockland, ME) gels containing 0.5× GelRed (Biotium, Fremont, CA), and pseudoexon inclusion was quantified from molar ratios between PCR products using the Fragment Analyzer system (Advanced Analytical Technologies, Ames, IA).
+ Open protocol
+ Expand
7

RNA Extraction and Sequencing for Viral Genomics

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA extraction was performed using the Quick-RNATM MiniPrep kit (Zymo Research, Irvine, CA, USA) and 200 µL of purified viral particles. Reverse transcription and double-stranded synthesis were carried out using the Maxima H Minus Double-Stranded cDNA Synthesis kit (Thermo Fisher Scientific, Waltham, MA, USA) and 13 µL of extracted RNA. Nextera™ DNA Flex Library Preparation kit (Illumina, San Diego, CA, USA) was used from 1 ng of double-strand cDNA. The libraries were purified with AMPure XP (Beckman Coulter, Indianapolis, IN, USA) and quantified with the Qubit dsDNA HS assay kit (Thermo Fisher Scientific, Waltham, MA, USA). The library’s quality and length were assessed with the Agilent high-sensitivity DNA kit (Agilent, Santa Clara, CA, USA) using a Fragment Analyzer™ System (Advanced Analytical Technologies, Inc., Heidelberg, Germany, Europe). Sequencing was performed on the MiniSeq and MiSeq platforms (Illumina, San Diego, CA, USA).
+ Open protocol
+ Expand
8

Bulk RNA-seq Analysis of FACS-sorted Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For bulk RNA-seq analysis, total RNA was extracted from FACS-sorted cells using a RNeasy Micro Kit (Qiagen, 74004). Strand-specific libraries were generated using an NEBNext Ultra RNA Library Prep Kit (NEB, E7530) following the manufacturer’s protocol. Libraries of 350±20 bp were obtained, and the quality was determined using a Fragment Analyzer system (Advanced Analytical).
Barcoded libraries were subjected to 150 bp paired-end sequencing on an Illumina HiSeq 2500, and the paired-end reads were aligned to the mouse reference genome (Version mm9 from UCSC) using Tophat (v2.0.13)(Trapnell et al., 2009 (link)). The expression value was generated as the number of fragments per kilobase of transcript per million mapped reads (FPKM) using Cufflinks (v2.2.1) (Trapnell et al., 2012 (link)).
+ Open protocol
+ Expand
9

Genomic DNA Extraction from PDX, FFPE, and Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from PDX, FFPE, and plasma cell-free DNA using the QIAamp DNA mini kit, QlAamp DNA FFPE Tissue Kit (Qiagen), and QIAamp DNA blood mini kit (Qiagen), respectively, according to the manufacturer’s instructions. Extracted DNA samples were quantified using a NanoDrop or Qubit™ dsDNA HS Assay Kit (Invitrogen). Genomic DNA integrity was determined with the Fragment Analyzer™ system (Advanced Analytical Technologies, Inc).
+ Open protocol
+ Expand
10

Quantifying Cell Lysis via DNA Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
In samples subjected to TS and LiCl extraction, cell lysis was investigated by determining the concentration of the released DNA fragments in the extracted cell surface protein extracts using a fragment analyzer system (Advanced Analytical Technologies Inc. USA). For this, 2 μL of the protein extract obtained by TS and LS treatment was mixed with 22 μL of genomic DNA diluent marker (DM) solution (Sigma-Aldrich, Australia) in a 96-well semiskirted PCR plate of the 12capillary system (Eppendorf, USA), and 2 μL of the genomic DNA ladder was added to 22 μL of the DM in well 12. Extracts obtained by suspending cells in distilled water and 0.05 M Tris buffer containing 40% sucrose, without TS or LS treatment, were used as negative controls. Extracts treated with 10 bursts of 1 min followed by 1 min cooling on ice between bursts using a TissueLyser II (Qiagen, Australia), as previously described, 38 (link) were used as positive controls. Samples were thoroughly mixed by vortexing. The system was then run initially at 6.0 kV for 30 s; sample injection then occurred at 0.5 kV for 5 s and sample separation occurred at 6.0 kV for 50.0 min.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!